http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101994677-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70596 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-04 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6872 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5047 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate | 2017-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101994677-B1 |
| titleOfInvention | A pharmaceutical composition comprising inhibitor of scavenger receptor |
| abstract | The present invention relates to a pharmaceutical composition for preventing or treating a disease caused by an Atg5 (Autophagy protein 5) gene defect containing an inhibitor for dendritic cells as an active ingredient, a scavenger receptor, , The pharmaceutical composition according to the present invention suppresses the expression or activity of the scavenger receptor of the dendritic cell which is abnormally expressed due to the deficiency of the Atg5 gene so that the immune activity of the dendritic cell is normally maintained, It is expected that it can be widely used for the prevention or treatment of all diseases caused by it. |
| priorityDate | 2017-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 58.